Healthcare ETF ASX | Health Sector ETF | BetaShares
  • Request info pack
  • Download factsheet
  • Request a call
  • Request Lonsec research
  • View all funds
  • Download Factsheet

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

Fund Objective

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Benefits of DRUG

Healthcare – a global growth opportunity

Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.

Simple access to global healthcare giants

Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.

Cost-effective

Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.

How to invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX.
  • Fund requires no minimum investment.

KEY FACTS

Pricing Information 4 July 2020

Current Price
Last Trade* -
% Change (prev day) -
Bid (delayed) -
Offer (delayed) -
*Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit * $6.57
* As at 2 July 2020

Profile

Net Assets* ($A) $48,673,820
Units Outstanding* (#) 7,411,695
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator RBC Investor Services
Custodian RBC Investor Services
Registry Link Market Services
Auditor KPMG
* As at 2 July 2020
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A
Market Makers Deutsche Securities
SMSF Eligible Yes

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN Index
Index Methodology

Portfolio Holdings

Name Weight (%)
JOHNSON & JOHNSON 7.7
UNITEDHEALTH GROUP INC 5.6
ROCHE HOLDING AG 5.4
NOVARTIS AG 4.8
PFIZER INC 4.3
MERCK & CO INC 3.9
ABBOTT LABORATORIES 3.5
ABBVIE INC 3.3
THERMO FISHER SCIENTIFIC INC 3.2
ELI LILLY AND CO 3.1
Ticker Name Weight (%) Asset Class Sector Country Currency Shares/Unit (#) Market Value (AUD) Notional Value (AUD)
JNJ UN JOHNSON & JOHNSON 7.7 Equities Healthcare United States USD 18,262 $3,710,036 $3,710,036
UNH UN UNITEDHEALTH GROUP INC 5.6 Equities Healthcare United States USD 6,329 $2,720,403 $2,720,403
ROG SE ROCHE HOLDING AG 5.4 Equities Healthcare Switzerland CHF 5,268 $2,639,217 $2,639,217
NOVN SE NOVARTIS AG 4.8 Equities Healthcare Switzerland CHF 18,500 $2,322,155 $2,322,155
PFE UN PFIZER INC 4.3 Equities Healthcare United States USD 41,655 $2,071,644 $2,071,644
MRK UN MERCK & CO INC 3.9 Equities Healthcare United States USD 16,826 $1,910,293 $1,910,293
ABT UN ABBOTT LABORATORIES 3.5 Equities Healthcare United States USD 12,652 $1,681,646 $1,681,646
ABBV UN ABBVIE INC 3.3 Equities Healthcare United States USD 11,120 $1,584,588 $1,584,588
TMO UN THERMO FISHER SCIENTIFIC INC 3.2 Equities Healthcare United States USD 2,974 $1,568,175 $1,568,175
LLY UN ELI LILLY AND CO 3.1 Equities Healthcare United States USD 6,337 $1,496,533 $1,496,533
AMGN UW AMGEN INC 3.0 Equities Healthcare United States USD 3,942 $1,467,044 $1,467,044
AZN LN ASTRAZENECA PLC 2.9 Equities Healthcare Britain GBP 9,090 $1,382,930 $1,382,930
BMY UN BRISTOL-MYERS SQUIBB CO 2.8 Equities Healthcare United States USD 16,186 $1,379,507 $1,379,507
MDT UN MEDTRONIC PLC 2.7 Equities Healthcare United States USD 9,586 $1,286,975 $1,286,975
NOVOB DC NOVO NORDISK A/S 2.5 Equities Healthcare Denmark DKK 12,556 $1,192,013 $1,192,013
SAN FP SANOFI 2.4 Equities Healthcare France EUR 8,029 $1,183,988 $1,183,988
GSK LN GLAXOSMITHKLINE PLC 2.1 Equities Healthcare Britain GBP 35,132 $1,027,277 $1,027,277
GILD UW GILEAD SCIENCES INC 1.9 Equities Healthcare United States USD 8,217 $904,119 $904,119
USD USD - UNITED STATES DOLLAR 1.7 Cash USD 572,159 $824,556 $824,556
BAYN GY BAYER AG 1.6 Equities Healthcare Germany EUR 6,953 $750,847 $750,847
ZTS UN ZOETIS INC 1.5 Equities Healthcare United States USD 3,576 $709,428 $709,428
BDX UN BECTON DICKINSON AND CO 1.5 Equities Healthcare United States USD 2,007 $708,712 $708,712
ANTM UN ANTHEM INC 1.4 Equities Healthcare United States USD 1,804 $694,146 $694,146
CI UN CIGNA CORP 1.4 Equities Healthcare United States USD 2,417 $663,517 $663,517
SYK UN STRYKER CORP 1.3 Equities Healthcare United States USD 2,459 $651,835 $651,835
VRTX UW VERTEX PHARMACEUTICALS INC 1.3 Equities Healthcare United States USD 1,523 $638,918 $638,918
ISRG UW INTUITIVE SURGICAL INC 1.3 Equities Healthcare United States USD 746 $624,064 $624,064
4502 JT TAKEDA PHARMACEUTICAL CO LTD 1.2 Equities Healthcare Japan JPY 11,900 $600,622 $600,622
4568 JT DAIICHI SANKYO CO LTD 1.1 Equities Healthcare Japan JPY 4,500 $519,929 $519,929
ILMN UW ILLUMINA INC 1.0 Equities Healthcare United States USD 892 $479,616 $479,616
HUM UN HUMANA INC 1.0 Equities Healthcare United States USD 831 $469,319 $469,319
PHIA NA KONINKLIJKE PHILIPS NV 1.0 Equities Healthcare Netherlands EUR 6,687 $465,359 $465,359
BSX UN BOSTON SCIENTIFIC CORP 1.0 Equities Healthcare United States USD 9,083 $463,117 $463,117
BAX UN BAXTER INTERNATIONAL INC 0.9 Equities Healthcare United States USD 3,532 $443,905 $443,905
REGN UW REGENERON PHARMACEUTICALS INC 0.9 Equities Healthcare United States USD 479 $429,678 $429,678
EW UN EDWARDS LIFESCIENCES CORP 0.9 Equities Healthcare United States USD 4,302 $428,960 $428,960
LONN SE LONZA GROUP AG 0.9 Equities Healthcare Switzerland CHF 544 $424,889 $424,889
EL FP ESSILORLUXOTTICA SA 0.9 Equities Consumer Discretionary France EUR 2,174 $416,763 $416,763
7741 JT HOYA CORP 0.8 Equities Healthcare Japan JPY 2,800 $394,398 $394,398
4519 JT CHUGAI PHARMACEUTICAL CO LTD 0.8 Equities Healthcare Japan JPY 5,100 $392,949 $392,949
BIIB UW BIOGEN INC 0.8 Equities Healthcare United States USD 1,002 $382,836 $382,836
DXCM UW DEXCOM INC 0.7 Equities Healthcare United States USD 580 $340,486 $340,486
CNC UN CENTENE CORP 0.7 Equities Healthcare United States USD 3,343 $320,473 $320,473
4503 JT ASTELLAS PHARMA INC 0.7 Equities Healthcare Japan JPY 13,400 $318,859 $318,859
COLOB DC COLOPLAST A/S 0.6 Equities Healthcare Denmark DKK 1,288 $287,909 $287,909
IQV UN IQVIA HOLDINGS INC 0.6 Equities Healthcare United States USD 1,395 $284,508 $284,508
ALC SE ALCON INC 0.6 Equities Healthcare Switzerland CHF 3,270 $277,125 $277,125
IDXX UW IDEXX LABORATORIES INC 0.5 Equities Healthcare United States USD 552 $266,303 $266,303
7733 JT OLYMPUS CORP 0.5 Equities Healthcare Japan JPY 9,800 $263,535 $263,535
RMD UN RESMED INC 0.5 Equities Healthcare United States USD 941 $261,023 $261,023
4543 JT TERUMO CORP 0.5 Equities Healthcare Japan JPY 4,700 $258,763 $258,763
HCA UN HCA HEALTHCARE INC 0.5 Equities Healthcare United States USD 1,801 $254,279 $254,279
ZBH UN ZIMMER BIOMET HOLDINGS INC 0.5 Equities Healthcare United States USD 1,436 $249,598 $249,598
ALXN UW ALEXION PHARMACEUTICALS INC 0.5 Equities Healthcare United States USD 1,452 $234,990 $234,990
4523 JT EISAI CO LTD 0.5 Equities Healthcare Japan JPY 2,000 $228,372 $228,372
4578 JT OTSUKA HOLDINGS CO LTD 0.5 Equities Healthcare Japan JPY 3,600 $221,795 $221,795
FRE GY FRESENIUS SE & CO KGAA 0.4 Equities Healthcare Germany EUR 2,777 $204,889 $204,889
ALGN UW ALIGN TECHNOLOGY INC 0.4 Equities Healthcare United States USD 506 $204,128 $204,128
FME GY FRESENIUS MEDICAL CARE AG & CO 0.4 Equities Healthcare Germany EUR 1,535 $194,369 $194,369
SN/ LN SMITH & NEPHEW PLC 0.4 Equities Healthcare Britain GBP 6,072 $172,219 $172,219
CHF CHF - SWISS FRANC 0.3 Cash CHF 97,601 $148,714 $148,714
JPY JPY - JAPANESE YEN 0.3 Cash JPY 9,747,353 $130,635 $130,635
207940 KP SAMSUNG BIOLOGICS CO LTD 0.2 Equities Healthcare South Korea KRW 121 $112,053 $112,053
GBP GBP - BRITISH POUND 0.2 Cash GBP 46,190 $83,075 $83,075
EUR EUR - EURO 0.1 Cash EUR 35,972 $58,293 $58,293
DKK DKK - DANISH KRONE 0.1 Cash DKK 164,168 $35,697 $35,697
CAD CAD - CANADA DOLLAR 0.0 Cash CAD 134 $142 $142
KRW KRW - KOREAN WON Cash KRW 1 $0 $0
AUD AUD - AUSTRALIA DOLLAR FX Forwards AUD 49,567,549 $49,567,549
CHF CHF - SWISS FRANC FX Forwards CHF -3,740,977 -$5,700,102
DKK DKK - DANISH KRONE FX Forwards DKK -6,774,137 -$1,472,991
EUR EUR - EURO FX Forwards EUR -1,974,636 -$3,199,864
GBP GBP - BRITISH POUND FX Forwards GBP -1,443,606 -$2,596,367
JPY JPY - JAPANESE YEN FX Forwards JPY -239,761,790 -$3,213,319
USD USD - UNITED STATES DOLLAR FX Forwards USD -22,051,766 -$31,779,458
AUD AUD - AUSTRALIA DOLLAR -2.2 Cash AUD -1,078,802 -$1,078,802 -$1,078,802
Download CSV
* As at 3 July 2020

Sector Allocation

Healthcare
100.0%
* As of 31 May 2020

Country Allocation

United States
66.7%
Switzerland
11.5%
Japan
6.9%
Britain
5.4%
France
3.1%
Denmark
3.1%
Germany
2.2%
Netherlands
0.8%
South Korea
0.2%
* As of 31 May 2020

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month 3.15% 3.26%
3 months 10.69% 10.86%
6 months 3.87% 4.17%
1 year 19.12% 19.81%
3 year p.a 10.27% 10.53%
5 year p.a - 6.98%
Since inception (p.a) 9.04% 9.31%
Inception date 4-Aug-16 -
* As at 29 May 2020

Chart

Chart Type
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) 0.4%
12 Mth Gross Distribution Yield* (%) -
Franking Level -
*As at 31 May 2020. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
2-Jan-20 3-Jan-20 17-Jan-20 $0.02494 0.46%
2-Jan-19 3-Jan-19 17-Jan-19 $0.01869 3.71%
2-Jul-18 3-Jul-18 17-Jul-18 $0.18445 3.77%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
Fund Flyer - DRUG
Download
Portfolio Holdings
Download
The Investment Case for DRUG
Download
Product Disclosure Statement - Global Sector Series
Download
Annual Report - June 2019
Download
NRWT and Fund Payment Notice information - December 2019 distributions
Download
Notice of Modifications to Fund Constitution – AMIT Tax Regime
Download
Index Methodology
Download
Interim Financial Report 2018
Download
2020 BetaShares Distribution Calendar
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack